These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Furst T; Dakwar GR; Zagato E; Lechanteur A; Remaut K; Evrard B; Braeckmans K; Piel G J Control Release; 2016 Aug; 236():68-78. PubMed ID: 27329774 [TBL] [Abstract][Full Text] [Related]
4. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying. D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019 [TBL] [Abstract][Full Text] [Related]
5. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation. Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus. Ensign LM; Lai SK; Wang YY; Yang M; Mert O; Hanes J; Cone R Biomacromolecules; 2014 Dec; 15(12):4403-9. PubMed ID: 25347518 [TBL] [Abstract][Full Text] [Related]
7. Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying. Agnoletti M; Bohr A; Thanki K; Wan F; Zeng X; Boetker JP; Yang M; Foged C Eur J Pharm Biopharm; 2017 Nov; 120():9-21. PubMed ID: 28780275 [TBL] [Abstract][Full Text] [Related]
8. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders. Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763 [TBL] [Abstract][Full Text] [Related]
9. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus. Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Kaur R; Garg T; Das Gupta U; Gupta P; Rath G; Goyal AK Artif Cells Nanomed Biotechnol; 2016; 44(1):182-7. PubMed ID: 24992699 [TBL] [Abstract][Full Text] [Related]
11. Development and in vitro/in vivo evaluation of HPMC/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent. Varshosaz J; Taymouri S; Minaiyan M; Rastegarnasab F; Baradaran A Drug Dev Ind Pharm; 2018 Feb; 44(2):276-288. PubMed ID: 29043860 [TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. Li X; Vogt FG; Hayes D; Mansour HM J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732 [TBL] [Abstract][Full Text] [Related]
13. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery. Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976 [TBL] [Abstract][Full Text] [Related]
14. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery. Odziomek M; Sosnowski TR; GradoĊ L Int J Pharm; 2012 Aug; 433(1-2):51-9. PubMed ID: 22580211 [TBL] [Abstract][Full Text] [Related]
15. Optimization and dissolution performance of spray-dried naproxen nano-crystals. Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034 [TBL] [Abstract][Full Text] [Related]
16. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597 [TBL] [Abstract][Full Text] [Related]
17. Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler: Sahastrabudhe H; Kenjale P; Pokharkar V Curr Drug Deliv; 2020; 17(8):703-710. PubMed ID: 32472998 [TBL] [Abstract][Full Text] [Related]
18. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery. Rattanupatam T; Srichana T Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124 [TBL] [Abstract][Full Text] [Related]
19. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Cheow WS; Ng ML; Kho K; Hadinoto K Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560 [TBL] [Abstract][Full Text] [Related]
20. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]